Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Synthelabo's device sales up 11% in first half:

This article was originally published in Clinica

Executive Summary

Synthelabo's medical device sales rose 11.4% to Fr 389 million ($76 million) in the first six months of 1996 compared with the previous year. Ela Medical achieved sales of Fr 288 million, an increase of 12.8% over the first half of 1995. Sales at Porges, Synthelabo's catheter division, were Fr 101 million, an increase of 7.4% on a comparable basis. Synthelabo group sales rose 10.9% in the first half of 1996 to Fr 5,122.6 million and the company says 1996 year sales should top Fr 10,000 million.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT088674

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel